Thijs L G, de Boer J P, de Groot M C, Hack C E
Medical Intensive Care Unit, Free University Hospital, Amsterdam, The Netherlands.
Intensive Care Med. 1993;19 Suppl 1:S8-15. doi: 10.1007/BF01738944.
Abnormalities in coagulation and fibrinolysis are frequently observed in septic shock. The most pronounced clinical manifestation is disseminated intravascular coagulation. Recent studies in human volunteers and animal models have clarified the early dynamics and route of activation of both coagulation and fibrinolytic pathways. In healthy subjects subjected to a low dose of either endotoxin or TNF an imbalance in the procoagulant and the fibrinolytic mechanisms is apparent, resulting in a procoagulant state. Also in patients with septic shock a dynamic process of coagulation and fibrinolysis is ongoing with evidence of impaired fibrinolysis. These abnormalities have prognostic significance; the extent of disturbances of coagulation and fibrinolysis is related to the development of multiple organ failure and death.
脓毒性休克患者常出现凝血和纤溶异常。最显著的临床表现是弥散性血管内凝血。最近在人类志愿者和动物模型中的研究阐明了凝血和纤溶途径激活的早期动态变化及途径。在接受低剂量内毒素或肿瘤坏死因子的健康受试者中,促凝和纤溶机制明显失衡,导致促凝状态。脓毒性休克患者也存在持续的凝血和纤溶动态过程,并有纤溶功能受损的证据。这些异常具有预后意义;凝血和纤溶紊乱的程度与多器官功能衰竭和死亡的发生有关。